Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/29/2005 | US20050287641 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
12/29/2005 | US20050287635 RTD receptor |
12/29/2005 | US20050287633 Vanilloid receptor |
12/29/2005 | US20050287630 Human antibodies derived from immunized xenomice |
12/29/2005 | US20050287624 Modified sarcosine oxidases, modified sarcosine oxidase genes, and methods for preparing the modified sarcosine oxidases |
12/29/2005 | US20050287604 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
12/29/2005 | US20050287602 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell |
12/29/2005 | US20050287588 Breast cancer specific gene 1 |
12/29/2005 | US20050287584 Secreted proteins encoded by human chromosome 13 |
12/29/2005 | US20050287579 Genes for male accessory gland proteins in Drosophila melanogaster |
12/29/2005 | US20050287568 Novel human transferase proteins and polynucleotides encoding the same |
12/29/2005 | US20050287557 Methods for identifying compounds for treating diabetes mellitus |
12/29/2005 | US20050287547 Embryonic stem cell markers and uses thereof |
12/29/2005 | US20050287546 Novel proteases |
12/29/2005 | US20050287542 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders |
12/29/2005 | US20050287530 TCL-1b gene and protein and related methods and compositions |
12/29/2005 | US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
12/29/2005 | US20050287514 Compositions and methods useful for HCV infection |
12/29/2005 | US20050287162 Recombinant fowlpox virus |
12/29/2005 | US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide |
12/29/2005 | US20050287150 Antibodies against Clostridium difficile toxins and uses thereof |
12/29/2005 | US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis |
12/29/2005 | US20050287129 Vectors and methods for long-term immune evasion to prolong transplant viability |
12/29/2005 | US20050287127 Use of stem cells to generate inner ear cells |
12/29/2005 | US20050287126 Ectocornea-like sheet and method of constructing the same |
12/29/2005 | US20050287125 Cell delivery fluid for prevention of cell settling in delivery system |
12/29/2005 | US20050287124 Method for inducing bone marrow-derived cells in injured epithelial site and a method for repairing injured epithelium |
12/29/2005 | US20050287122 Adeno-associated virus vectors with modified capsid proteins for use as gene transfer and proliferation tools; gene therapy; genetic vaccines |
12/29/2005 | US20050287118 Bacterial plasmid with immunological adjuvant function and uses thereof |
12/29/2005 | US20050287116 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
12/29/2005 | CA2735315A1 Plastid transit peptides |
12/29/2005 | CA2734716A1 Plastid transit peptides |
12/29/2005 | CA2734624A1 Plastid transit peptides |
12/29/2005 | CA2734561A1 Plastid transit peptides |
12/29/2005 | CA2591858A1 Proteases derived from norcardiopsis |
12/29/2005 | CA2570395A1 Antibodies binding to cd34+/cd36+ fetal but not to adult cells |
12/29/2005 | CA2570086A1 Medium and methods for culturing of avian primordial germ cells |
12/29/2005 | CA2569953A1 Novel maize split-seed explant and methods for in vitro regeneration of maize |
12/29/2005 | CA2567975A1 Stem cell maturation for all tissue lines |
12/29/2005 | CA2567692A1 Therapeutic reprogramming, hybrid stem cells and maturation |
12/29/2005 | CA2565972A1 Ex-vivo application of solid microparticulate therapeutic agents |
12/28/2005 | EP1609867A1 Nucleic acid construct, expression vector and method for enhancing the production of recombinant protein |
12/28/2005 | EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP) |
12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/28/2005 | EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
12/28/2005 | EP1609853A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
12/28/2005 | EP1609851A1 Apparatus and method for machining microchamber for cell culture |
12/28/2005 | EP1609493A1 Use of three-dimensional prostheses containing hyaluronic acid derivatives |
12/28/2005 | EP1608967A2 Compositions and methods for the diagnosis and treatment of tumor |
12/28/2005 | EP1608963A2 Apparatus and methods for providing sex-sorted animal sperm |
12/28/2005 | EP1608962A2 Model for neurodegenerative disorders |
12/28/2005 | EP1608743A2 Phosphodiesterase 10a7 isoforms and methods of use |
12/28/2005 | EP1608740A1 Differentiation of human embryonic stem cells to cardiomyocytes |
12/28/2005 | EP1608739A2 Canine embryonic stem cells |
12/28/2005 | EP1608738A2 Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
12/28/2005 | EP1608728A2 Materials and methods for regulating process formation in cell culture |
12/28/2005 | EP1608684A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
12/28/2005 | EP1608683A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
12/28/2005 | EP1608681A2 Rgd-enriched gelatine-like proteins with enhanced cell binding |
12/28/2005 | EP1608672A2 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
12/28/2005 | EP1608382A1 Process for the staining of sperm |
12/28/2005 | EP1575572A3 Collagen biofabric and methods of preparation and use therefor |
12/28/2005 | EP1516056A4 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
12/28/2005 | EP1490013A4 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
12/28/2005 | EP1379539A4 Methods and materials for making and using transgenic dicamba-degrading organisms |
12/28/2005 | EP1335987B1 Modified vaccinia ankara virus variant |
12/28/2005 | EP1326597B1 Use of kcnq potassium channel agonists for the manufacture of a medicament for modulating bladder function |
12/28/2005 | EP1284597A4 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides |
12/28/2005 | EP1191937A4 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins |
12/28/2005 | EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides |
12/28/2005 | EP1092037B1 Cell culture process for producing glycoproteins |
12/28/2005 | EP1073683B1 G-csf receptor agonist antibodies and screening method therefor |
12/28/2005 | EP1053302B1 Expanded and genetically modified populations of human hematopoietic stem cells |
12/28/2005 | EP1025240B1 Multiply-substituted protease variants with altered net charge for use in detergents |
12/28/2005 | EP1025227B1 Human toll homologues |
12/28/2005 | EP1025129B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
12/28/2005 | EP1011717B1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
12/28/2005 | EP0971959B1 Humanized antibodies and methods for forming humanized antibodies |
12/28/2005 | EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
12/28/2005 | EP0879281B1 Methods for transforming dendritic cells and activating t cells |
12/28/2005 | EP0859840B1 Biologically active eph family ligands |
12/28/2005 | EP0828820B1 Compositions and methods to prevent microbial contamination of plant tissue culture media |
12/28/2005 | EP0797676B1 Recombinant adenoviral vector and methods of use |
12/28/2005 | EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity |
12/28/2005 | EP0672159B1 Homologous sequence targeting in eukaryotic cells |
12/28/2005 | CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
12/28/2005 | CN1714147A Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
12/28/2005 | CN1713951A Tangential flow filtration devices and methods for leukocyte enrichment |
12/28/2005 | CN1713861A Vascularization enhanced graft constructs |
12/28/2005 | CN1712534A Nucleic acid structure and expression carrier for enhancing recombinant protein production and mass-production of recombinant protein |
12/28/2005 | CN1712523A Monocloned antibody against endothelial chalone and its hybrid tumor cell system and use |
12/28/2005 | CN1712522A In vitro purification of self-sanguifacient dry cell and kit |
12/28/2005 | CN1712521A Lung cancer strain with high potential power of bone transference and its generation |
12/28/2005 | CN1712520A Subgroup separation of primitive dry cell, induced differentiation and process for treating cardiovascular disease |
12/28/2005 | CN1712519A Liquid for preserving pig semen |
12/28/2005 | CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage |
12/28/2005 | CN1233822C Interleukin-15 gene modified natural killing cell strain and its preparation method |
12/28/2005 | CN1233821C Method of separating pork liver stem cell |
12/28/2005 | CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease |
12/27/2005 | US6979765 Inbred corn line G6103 |